Andreas Halvorsen acquired 1.09 Million Viking Therapeutics shares worth $85.4 Million. That's 0.32% of their equity portfolio (59th largest holding). Andreas Halvorsen started to build up the position in Viking Therapeutics in Q1 2023 and continued to invest until Q4 2023. Since then they sold 4.05 Million shares. The stake costed the investor $16.1 Million, netting the investor a gain of 430% so far.